Skip to main content

Table 2 Cumulative incidencea of most common cancer entities after 10 years of follow-up

From: Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis

 

RPE only [%]

RT only [%]

RT after RPE [%]

p-value*

All second cancer

10.5

15.9

13.2

<.0001

Colon cancer

1.1

1.7

2.0

0.0017

Rectal cancer

0.6

1.1

0.3

0.0036

Lung cancer

1.2

2.2

1.2

<.0001

Bladder cancer

1.1

2.7

1.5

<.0001

Non-melanoma skin cancer

1.2

2.1

1.6

<.0001

  1. aTo account for competing risks, like death, cumulative incidence analysis was used to calculate time to second malignancy
  2. *p-value was calculated by Gray-Test